Article
In vivo correction of a Menkes disease model using antisense oligonucleotides.
Proceedings of the National Academy of Sciences of the United States of America - 11 Mar 2008
Madsen Erik C, Morcos Paul A, Mendelsohn Bryce A, Gitlin Jonathan D
Abstract excerpt
Although the molecular basis of many inherited metabolic diseases has been defined, the availability of effective therapies in such disorders remains problematic. Menkes disease is a fatal neurodegenerative disorder due to loss-of-function mutations in the ATP7A gene encoding a copper-transporting P-type Atpase. To develop therapeutic approaches in affected patients, we have identified a zebrafish model of Menkes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
